Hypoadiponectinemia is associated with nonalcoholic hepatic steatosis in obese subjects.
Answers are grounded in this paper and cite their sources.
Does not warrant practice change; leaves open causal role of hypoadiponectinemia in steatosis.
Nonalcoholic fatty liver disease is a clinicopathological syndrome that is closely associated with obesity and other metabolic syndrome features (1). Recent research has shown that adiponectin is a novel adipocyte-derived hormone with antidiabetic and antiatherogenic properties (2). In humans, plasma adiponectin levels are significantly lower in insulin-resistant states (2), thus suggesting that this adipocytokine is an important marker of the metabolic syndrome. Administration of adiponectin to mice has been shown to produce beneficial effects on glucose metabolism (2). Furthermore, administration of this protein was also effective in ameliorating liver biopsy features and liver test results in ob/ob mice (3). Accordingly, after controlling for age, sex, and …
No takes yet. Share an insight, caveat, or question.
Targher et al. (2004) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: